The information in this article is from HCUPnet, an online query system that provides access to health statistics and information on hospital stays from the Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for Healthcare Research and Quality (AHRQ). This project includes the largest set of publicly available databases on all patients in the United States, regardless of type of insurance or whether the patients had insurance. To access HCUPnet, go to http://hcup.ahrq.gov/HCUPnet.asp.
Spending on prescription drugs to treat depression, anxiety, pain, schizophrenia, and other conditions climbed from $7.9 billion in 1997 to $20 billion in 2004 -- over a 150% increase, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
AHRQ, a part of the US Department of Health and Human Services, works to improve the quality, safety, efficiency, and effectiveness of healthcare in the United States. The data in this AHRQ News and Numbers come from the Agency's Medical Expenditure Panel Survey, a highly detailed source of information on the health services that Americans use, how frequently they use them, the cost of these services, and how they are paid.
For more information on this AHRQ News and Numbers, see Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004.